Turn on more accessible mode
Turn off more accessible mode
Sign In
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Home
Who We Are
HSN Leadership
Seminars
Projects
Publications
Image Caption
Page Image
DOR Page Content 1
Previous
Next
DOR Page Content 2
DOR Page Content 3
DOR Page Content 4
Scientific Focus
Improve health outcomes of substance use and substance use disorder for individuals who are not in treatment.
Improve substance use disorder treatment outcomes.
Improve the rigor of pragmatic trials through methodological innovation.
DOR Page Content 5
Who We Are
The Health Systems Node (HSN) is a collaboration of investigators who conduct substance use and substance use disorder research embedded in health systems across the United States.
The HSN designs and conducts pragmatic trials within health systems including the
Health Care Systems Research Network
, Federally Qualified Health Centers, the Veterans Health Administration, and affiliated hospitals.
Investigators in the HSN have extensive expertise conducting pragmatic trials and observational comparative effectiveness research aimed at improving prevention and treatment of substance use and substance use disorder in medical settings to minimize impact on health.
The HSN is led by
Cynthia Campbell, PhD, MPH
at the
Kaiser Permanente Northern California Division of Research
,
Katharine Bradley, MD, MPH
at the
Kaiser Permanente Washington Health Research Institute
in Seattle and
Ingrid Binswanger, MD, MPH, MS
at the
Kaiser Permanente Colorado Institute for Health Research
.
DOR Page Content 6
Projects
Pragmatic trials
testing innovative approaches to improving treatment and medical care for patients with substance use and substance use disorders
. Pragmatic trials that the HSN has led or participated in:
PROUD Trial
,
COMPUTE 2.0
,
Office-based Methadone Trial – EMBOSS
,
Co-CARE
.
Comparative effectiveness and other health services research
using innovative health system data to address the opioid crisis, cannabis use, and other important research areas
. Studies the HSN has led:
Virtual Data Warehouse
,
HEDIS AOD-IET Measure Performance
,
Prescription Opioid Registry
,
Determining Optimal Duration of Buprenorphine Treatment
,
COVID and SUD Treatment
,
Cannabis use and Pregnancy
,
Insurance Instability and Mortality
.
Innovative methods research aimed at improving preventive screening and assessment
for substance use and substance use disorders as part of routine care
. Studies the HSN has led:
Evaluation of Drug Screening Implementation
,
Evaluation of Medical Cannabis Documentation
,
Validating Substance Use Symptom Checklist
.
Page Content
Contact: Monique Buffler
4480 Hacienda Drive, Pleasanton, CA 94588
NIDA Clinical Trials Network